FEDERATED HERMES, INC.

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1056288 PITTSBURGH, PA

Position in CRBP

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,329

-$6,183 QoQ

Shares Held

355

-65.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#82

of 106 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. CRBP ranks #141 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,329	355	-65.0%	Shares	Defined	2026-08-12
2026-03-31	$9,512	1,013	+3.5%	Shares	Defined	2026-05-11
2025-12-31	$7,969	979	+0.6%	Shares	Defined	2026-02-12
2025-09-30	$12,308	973	-13.9%	Shares	Defined	2025-11-03
2025-06-30	$7,797	1,130	+1665.6%	Shares	Defined	2025-08-13
2025-03-31	$339	64	-95.9%	Shares	Defined	2025-05-08
2022-03-31	$826	1,553	-11.9%	Shares	Defined	2022-05-13
2021-12-31	$1,085	1,762	0.0%	Shares	Defined	2022-02-14
2021-09-30	$1,797	1,762	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.